Tofaq 5 Tablet 1 Substitute
by AYUR
by Others
by AYUR
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
Composition:
TOFACITINIB-5MG
Uses:
<p>Tofaq 5 Tablet 1 is used in the treatment of Rheumatoid arthritis, Psoriatic arthritis, and Ulcerative colitis. The detailed uses of Tofaq 5 Tablet 1 are as follows:</p><ul><li><strong>Treatment of Rheumatoid Arthritis: </strong>Tofaq 5 Tablet 1 helps to manage moderate to severe rheumatoid arthritis by reducing joint pain, inflammation, and slowing disease progression.</li><li><strong>Management of Psoriatic Arthritis:</strong> Tofaq 5 Tablet 1 treats active psoriatic arthritis by reducing joint pain, swelling, stiffness, and improving overall joint function.</li><li><strong>Treatment of Ulcerative Colitis:</strong> Tofaq 5 Tablet 1 helps to induce and maintain remission in moderate to severe ulcerative colitis.</li></ul>
Medicinal Benefits:
Tofaq 5 Tablet 1 is used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofaq 5 Tablet 1 works by blocking Janus kinase enzyme, thereby lowers inflammation and symptoms associated with rheumatoid and psoriatic arthritis.
Hypertension/high blood pressure could be a side-effect of Tofaq 5 Tablet 1. Consult your doctor before taking Tofaq 5 Tablet 1 if you have high blood pressure or if you are taking anti-hypertensive medicines.
Diarrhoea might be a side-effect of Tofaq 5 Tablet 1. Eat non-spicy meals and drink plenty of fluids to prevent dehydration if you experience diarrhoea. If you find blood in stools (tarry stools) or if you experience severe diarrhoea, consult your doctor. Do not take anti-diarrheal medicine on your own.
Tofaq 5 Tablet 1 might impair fertility in females of reproductive potential. It is not known if the effect is reversible. Therefore, talk to a doctor before starting Tofaq 5 Tablet 1 if you are trying to become pregnant or if you have any concerns regarding this.
Tofaq 5 Tablet 1 affects the immune system and might lower the ability of the immune system to fight infections. Inform your doctor if you have an active infection, if you have a condition that increases the chance of having infections, if you are taking immunosuppressants, medicines that affect the immune system or corticosteroids.
Tofaq 5 Tablet 1 is not recommended for patients with severe liver impairment. Dose adjustment may be needed in patients with mild to moderate liver impairment. Please consult the doctor if you have liver problems.
Tofaq 5 Tablet 1 may increase the risk of cancer by changing the way the immune system works. Inform the doctor if you ever had any type of cancer.
Tofaq 5 Tablet 1 may begin working within 2-8 weeks after starting the treatment.
Tofaq 5 Tablet 1 should not be taken along with tocilizumab as it might increase the risk of infections. Before starting Tofaq 5 Tablet 1, inform the doctor if you are taking tocilizumab.
Prior to starting Tofaq 5 Tablet 1, active or latent tuberculosis test, CBC (complete blood count), LFT (liver function test), and lipid profile tests should be done.